rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
4
|
pubmed:dateCreated |
1996-10-2
|
pubmed:abstractText |
The treatment of uraemic patients with recombinant human erythropoietin (rHuEpo) often leads to an increase in blood pressure. Indirect and direct effects of the hormone are probably involved. We explored the possibility of a direct action on the vascular smooth muscle cell (VSMC).
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0931-0509
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
11
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
687-92
|
pubmed:dateRevised |
2010-3-24
|
pubmed:meshHeading |
pubmed-meshheading:8671860-Animals,
pubmed-meshheading:8671860-Aorta,
pubmed-meshheading:8671860-Blotting, Northern,
pubmed-meshheading:8671860-Blotting, Southern,
pubmed-meshheading:8671860-Cell Division,
pubmed-meshheading:8671860-Cells, Cultured,
pubmed-meshheading:8671860-DNA,
pubmed-meshheading:8671860-DNA Replication,
pubmed-meshheading:8671860-Erythropoietin,
pubmed-meshheading:8671860-Hypertension,
pubmed-meshheading:8671860-Male,
pubmed-meshheading:8671860-Muscle, Smooth, Vascular,
pubmed-meshheading:8671860-RNA, Messenger,
pubmed-meshheading:8671860-Rats,
pubmed-meshheading:8671860-Rats, Inbred SHR,
pubmed-meshheading:8671860-Rats, Inbred WKY,
pubmed-meshheading:8671860-Receptors, Erythropoietin,
pubmed-meshheading:8671860-Recombinant Proteins
|
pubmed:year |
1996
|
pubmed:articleTitle |
Direct effect of erythropoietin on rat vascular smooth-muscle cell via a putative erythropoietin receptor.
|
pubmed:affiliation |
INSERM Unité 90, Hôpital Necker, Paris, France.
|
pubmed:publicationType |
Journal Article
|